leadf
logo-loader
viewDalrada Financial Corp
(
OTCQB:DFCO
)

Dalrada taps Captain David Bacon to its board as it advances its health product lines

CEO Brian Bonar said Dr Bacon’s background in conducting extensive evidence-based research will be “extremely valuable” for Dalrada Health’s product lines

Dalrada Financial Corp - Dalrada taps Captain David Bacon to the company’s board as it advances health product lines
The senior US officer has been working on infectious disease research for more than two decades

Dalrada Corporation (OTCQB:DFCO) said that it has appointed well-known medical expert and US Navy Captain Dr David Bacon to the company’s board, as the group focuses on advancing Dalrada Health’s product lines. 

Dr Bacon is an active US Navy Captain with 22 years of service. During the coronavirus (COVID-19) pandemic, Dr Bacon was responsible for reviewing proposals for funding in the areas of therapeutics, diagnostics, and wearable monitors. He reviewed more than 400 proposals and provided his expert opinion on the scientific rationale and study design, said the company. 

The senior US officer has been working on infectious disease research for more than two decades. After graduate school, he started a post-doctoral fellowship in the Enteric Disease Department at the Naval Medical Research Center (NMRC), in Silver Spring and was commissioned as a lieutenant in 1999.

READ: Dalrada Corporation sees FY3Q revenue jump triple digits year-over-year as growth accelerates

After September 11, 2001, Dr Bacon trained as an officer-in-charge of a bio-warfare detection team in support of the Biological Defense Research Directorate at NMRC. Dr Bacon deployed as element commander of a biological weapons detection lab, in Baghdad, Iraq. He was also a member of the scientific assessment team commissioned by the Iraq Survey Group to investigate biological weapons programs in Iraq.

Dr Bacon has been the former program area manager, for the US Department of Defense’s HIV and Emerging Infectious Diseases research programs.

In a statement, Dalrada CEO Brian Bonar said: “We are thrilled that Dr Bacon has accepted a role with Dalrada’s Board of Directors. His extensive background of conducting, directing, and developing evidence-based research will be extremely valuable insight for accelerated availability of Dalrada Health’s product lines.”

Dalrada said Dr Bacon now joins CEO Bonar, Tom Giles, Pauline Gourdie, Harvey Herskowitz, Brian Kendrick, Fawad Nisar, Fletcher Robbe and Anthony Zolezzi on the company’s board.

Contact the author Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive

Quick facts: Dalrada Financial Corp

Follow
OTCQB:DFCO

Price: 0.32 USD

Market Cap: $23.12 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Dalrada COO talks through IT engineering subsidiary Prakat Solutions'...

Dalrada Corporation (OTCQB:DFCO) COO Fawad Nisar tells Proactive the group's IT engineering subsidiary Prakat Solutions Inc has partnered with Singapore-based ValueQwest Private Limited to expand the digital transformation of global supply chains. Nisar says Prakat’s software engineering team...

on 07/27/2021

2 min read